Differential effects of interleukin-13 on cytomegalovirus and human immunodeficiency virus infection in human Alveolar macrophages

Blood

Volumn 89, Issue 9, 1997, Pages 3443-3450

  Hatch, William C ^a,b   Freedman, Andrew R ^a   Boldt Houle, Deborah M ^a   Groopman, Jerome E ^a   Terwilliger, Ernest F ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; NORMAL HUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS REPLICATION;

EID: 0030996969     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.9.3443     Document Type: Article

References (58)

1. Montaner LJ, Doyle AG, Collin M, Herbein G, Illei P, James W, Minty A, Caput D, Ferrara P, Gordon S: Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary bloodderived human macrophages in vitro. J Exp Med 178:743, 1993
2. de Waal Malefyt R, Figdor CG, Huijbens R, Nohan-Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, de Vries JE: Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. J Immunol 151:6370, 1993
3. Zurawski G, de Vries JE: Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 15:19, 1994
4. Okamoto T, Matsuyama T, Mori S, Hamamoto Y, Kobayashi N, Yamamoto N, Josephs SF, Wong-Staal F, Shimotohno K: Augmentation of human immunodeficiency virus type 1 gene expression by tumor necrosis factor a. AIDS Res Hum Retrovir 5:131, 1989
5. Kobayashi N, Hamamoto Y, Koyanagi Y, Chen ISY, Yamamoto N: Effect of interleukin-l on the augmentation of human immunodeficiency virus gene expression. Biochem Biophys Res Commun 165:715, 1989
6. Koyanagi Y, O'Brien WA, Zhao JQ, Golde DW, Gasson JC, Chen ISY: Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 241:1673, 1988
7. Poli G, Bressler P, Kinter A, Duh E, Timmer WC, Rabson A, Justement JS, Stanley S, Fauci AS: Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor a by transcriptional and post-transcriptional mechanisms. J Exp Med 151:151, 1990
8. Poli G, Fauci AS: The effect of cytokines and pharmacologie agents on chronic HIV infection. AIDS Res Hum Retrovir 8:191, 1992
9. Farrar WL, Koner M, Clouse KA: Cytokine regulation of human immunodeficiency virus expression. Cytokine 3:531, 1991
10. Denis M, Ghadirian E: Interleukin 13 and interleukin 4 protect bronchoalveolar macrophages from productive infection with human immunodeficiency virus type 1. AIDS Res Hum Retrovir 10:795, 1994
11. Dickson DW, Lee SC, Hatch W, Mattiace LA, Brosnan CF, Lyman WD: Macrophages and microglia in HIV-related CNS neuropathology (Review). Res Publ Assoc Res Nerv Ment Dis 72:99, 1994
12. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359, 1993
13. Fauci AS: Multifactorial nature of human immunodeficiency disease: Implications for therapy. Science 262:1011, 1993
14. Geleziunaz R, Schipper HM, Wainberg MA: Pathogenesis and therapy of H1V-1 infection of the central nervous system. AIDS 6:1411, 1992
15. Spiegel H, Herbst H, Niedobitek G, Foss HD, Stein H: Follicular dendritic cells area major reservoir of human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells. Am J Pathol 140:15, 1992
16. Weiss RA: How does HIV cause AIDS? Science 260:1273, 1993
17. Jacobson MA, Mills J: Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 108:585, 1988
18. Rubin RH, Cosimi AB, Tolkoff-Rubin NE, Russell PS, Hirsch MS: Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplantation recipients. Transplantation 24:458, 1977
19. Zial JA: Viral infections associated with bone marrow transplantation. Hematol Oncol Clin North Am 4:603, 1990
20. Speich R, Opravil M, Landolt U, Vogt P, Hess T, Weber R, Grebski E, Luethy R, Russi EW: AIDS-associated cytomegalovirus pneumonia: Significance of cytopathogenic viral effects in bronchoalveolar lavage (BAL) cells. Chest 103:2275, 1993 (suppl)
21. Baithesen M, Messerle M, Reddehase MJ: Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol 67:5360, 1993
22. Dankner WM, McCutchan JA, Richman DD, Hirata K, Spector SA: Localization of human cytomegalovirus in peripheral bood leukocytes by m situ hybridization. J Infect Dis 161:31, 1990
23. Fajac A, Vidaud M, Lebargy F, Stephan F, Ricci S, Geslin P, Goossens M, Bemaudin JF: Evaluation of human cytomegalovirus latency in alveolar macrophages. Am J Respir Crit Care Med 149:495, 1994
24. Nelson JA, Reynolds-Kohler C, Oldstone MBA, Wiley CA: HIV and HCMV coinfect brain cells in patients with AIDS. Virology 165:286, 1988
25. Skolnik PR, Pomerantz RJ, de la Monte SM, Lee SF, Hsiung GD, Foos RY, Cowan GM, Kosloff RR, Hirsch MS, Pepose JS: Dual infection of retina with human immunodeficiency virus type I and cytomegalovirus. Am J Ophthalmol 107:361, 1989
26. Rich EA, Tweardy DJ, Fujiwara H, Ellner JJ: Spectrum of immunoregulatory functions and properties of human alveolar macrophages. Am Rev Respir Dis 136:258, 1987
27. Chayt KJ, Harper ME, Marselle LM, Lewin EB, Rose RM, Oleske JM, Epstein LG, Wong-Staal F, Gallo RC: Detection of HTLV III RNA in lungs of patients with AIDS and pulmonary involvement. J Am Med Assoc 256:2356, 1986
28. Israel-Biet D, Cadranel J, Beldjord K, Andrieu JM, Jeffrey A, Even P: Tumor necrosis factor production in HIV-seropositive subjects. J Immunol 147:490, 1991
29. Rich EA, Chen ISY, Zack JA, Leonard ML, O'Brien WA: Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest 89:176, 1992
30. Rose RM, Krivine A, Pinkston P, Gillis JM, Huang A, Hammer SM: Frequent identification of HIV-1 DNA in bronchoalveolar lavage cells obtained from individuals with the acquired immunodeficiency syndrome. Am Rev Respir Dis 143:850, 1991
31. Salahuddin SZ, Rose RM, Groopman JE, Markham PD, Gallo RC: Human T lymphotropic virus type III infection of human alveolar macrophages. Blood 68:281, 1986
32. Agostini C, Zambello R, Trentin L, Garbisa S, Francis di Celle P, Bullan P, Onisto M, Poletti V, Spriga L, Raise E, Foa R, Semenzato O: Alveolar macrophages from patients with AIDS and AIDS-related complex constitutively synthesize and release tumor necrosis factor alpha. Alveolar macrophages. Rev Respir Dis 143:195, 1991
33. Agostini C, Trentin L, Zambello R, Bulian P, Caenazzo C, Cipriani A, Cadrobbi P, Garbisa S, Semenzato G: Release of granulocyte-macrophage colony-stimulating factor by alveolar macrophages in the lung of HIV-1 infected patients. J Immunol 149:3379, 1992
34. Krishnan VL, Meager A, Mitchell DM, Pinching AJ: Alveolar macrophages in AIDS patients; increased spontaneous tumor necrosis factor-alpha production in Pneumocystis carinii pneumonia. Clin Exp Immunol 80:158, 1990
35. Millar A, Miller RF, Neoleen MF, Semple SJG, Rook GAW: Production of tumor necrosis factor by blood and lung mononuclear cells from patients with human immunodeficiency virus-related lung disease. Am J Respir Cell Mol Biol 5:144, 1991
36. Trentin L, Garbisa S, Zambello R, Agostini C, Caenazzo C, Di Francesco C, Cipriani A, Francavilla E, Semenzalo G: Spontaneous production of IL-6 by alveolar macrophages of HIV-1 seropositive patients. J Infect Dis 166:731, 1992
37. Jeffrey AA, Israel-Biet D, Andrieu JM, Even P, Venet A: HIV isolation from pulmonary cells derived from broncheolar lavage. Clin Exp Immunol 84:488, 1991
38. Sierra-Madero J, Toossi Z, Horn DL, Finegan CK, Hoenig E, Rich EA: Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type 1-infected persons, production of cytokines, and clinical status. J Infect Dis 169:18, 1994
39. Ghazal P, Nelson J: Interactions between cytomegalovirus immediate early proteins and the long terminal repeat of human immunodeficiency virus. Rev Med Virol 3:47, 1993
40. Koval V, Clark C, Vaishnav M, Spector SA, Spector DH: Human cytomegalovirus inhibits human immunodeficiency virus replication in cells productively infected by both viruses. J Virol 65:6969, 1991
41. Finkle C, Tapper MA, Knox KK, Carrigan DR: Coinfection of cells with the human immunodeficiency virus and cytomegalovirus in lung tissues of patients with AIDS. J AIDS 4:735, 1991
42. Hirka G, Prakash K, Kawashima H, Plotkin SA, Andrews PW, Gonczol E: Differentiation of human embryonal carcinoma cells induces human immunodeficiency virus permissiveness which is stimulated by human cytomegalovirus coinfection. J Virol 65:2732, 1991
43. Jaulat FM, Spector SA, Spector DH: The effects of cytomegalovirus on human immunodeficiency virus replication in brain-derived cells correlate with permissiveness of the cells for each virus. J Virol 68:959, 1994
44. Lathey JL, Spector DH, Spector SA: Human cytomegalovirus-mediated enhancement of human immunodeficiency virus type1 production in monocyte-derived macrophages. Virology 199:98, 1994
45. Spaete RR, Mocarski ES: Insertion and deletion mutagenesis of the human cytomegalovirus genome. Proc Nail Acad Sci USA 84:7213, 1987
46. Wentworth BB, French L: Plaque assay of cytomegalovirus strains of human origin. Proc Soc Exp Biol Med 135:253, 1970
47. Hatch WC, Pousada E, Losev L, Rashbaum WK, Lyman WD: Neural cell targets of HIV-1 in human fetal organotypic cultures. AIDS Res Hum Retrovir 10:1597, 1994
48. Huffman AD, Banapour B, Levy JA: Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 147:326, 1985
49. Mattiace LA, Davies P, Dickson DW: Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am J Pathol 136:1101, 1990
50. Du B, Wu P, Boldt-Houle DM, Terwilliger EF: Efficient transduction of human neurons with an adeno-associated virus vector. Gene Ther 3:254, 1996
51. Kimpton J, Emerman M: Detection of replication competent and pseudotyped HIV with a sensitive cell line based on activation of an integrated beta-galactosidase gene. J Virol 66:2232, 1992
52. Ehrlich GD, Greenberg S, Abbott M: A guide to methods and applications, in Innis MA, Gelfand DH, Sninsky JT, White TJ (eds): PCR Protocols. San Diego, CA, Academic, 1990, p 325
53. Stinski MF: Cytomegalovirus and its replication, in Fields BN, Knipe DM, Chanock RM, Melnick JJ, Shope RE (eds): Virology. New York, NY, Raven, 1990, p 1959
54. Minton EJ, Tysoe C, Sinclair JH, Sissons JG: Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J Virol 68: 4017, 1994
55. Krugman RD, Goodheart CR: Human cytomegalovirus. Thermal inactivation. Virology 23:290, 1965
56. Plummer G, Lewis B: Thermoinactivation of herpes simplex virus and cytomegalovirus. J Bacteriol 89:671, 1965
57. Gooding LR: Virus proteins that counteract host immune defenses. Cell 71:5, 1992
58. Koszinowski UH, Jonjic S, Lucin P: Cytomegalovirus persistence by evasion from immune control. Sem Virol 5:297, 1994